Outlook Therapeutics, Inc. (OTLK): Price and Financial Metrics
OTLK Price/Volume Stats
| Current price | $1.44 | 52-week high | $12.85 |
| Prev. close | $1.39 | 52-week low | $0.87 |
| Day low | $1.34 | Volume | 723,100 |
| Day high | $1.47 | Avg. volume | 695,755 |
| 50-day MA | $4.24 | Dividend yield | N/A |
| 200-day MA | $6.73 | Market Cap | 34.06M |
OTLK Stock Price Chart Interactive Chart >
Outlook Therapeutics, Inc. (OTLK) Company Bio
Outlook Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company engages in identifying, developing, manufacturing, and commercializing complex biosimilar therapeutics. Outlook Therapeutics focuses on monoclonal antibodies in the disease areas of immunology and oncology aspects. Outlook Therapeutics offers its services in the United States.
OTLK Price Returns
| 1-mo | -71.93% |
| 3-mo | -76.00% |
| 6-mo | -80.62% |
| 1-year | -82.98% |
| 3-year | -94.82% |
| 5-year | -87.59% |
| YTD | -81.73% |
| 2023 | -63.52% |
| 2022 | -20.59% |
| 2021 | 4.62% |
| 2020 | 120.34% |
| 2019 | -85.25% |
Continue Researching OTLK
Here are a few links from around the web to help you further your research on Outlook Therapeutics Inc's stock as an investment opportunity:Outlook Therapeutics Inc (OTLK) Stock Price | Nasdaq
Outlook Therapeutics Inc (OTLK) Stock Quote, History and News - Yahoo Finance
Outlook Therapeutics Inc (OTLK) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...